COMMUNIQUÉS West-GlobeNewswire

Terveystalo Plc: Resolutions of Annual General Meeting
04/04/2019
Terveystalo Plc, Stock Exchange Release 4 April 2019 at 17:15 EEST The Annual General Meeting of Terveystalo Plc was held today on 4 April 2019 in Helsinki, Finland. The Annual General Meeting adopted the financial [...]
eSolutions Inc. Achieves HITRUST CSF® Certification and HITRUST Certification of the NIST Cybersecurity Framework to Manage Risk, Improve Security Posture and Meet Compliance Requirements
04/04/2019
HITRUST CSF Certification and HITRUST Certification of the NIST Cybersecurity Framework validates eSolutions Inc. is committed to meeting key regulations and protecting sensitive information OVERLAND PARK, Kan., April [...]
ENLIVEX THERAPEUTICS TO PRESENT AT THE 2019 H.C. WAINWRIGHT GLOBAL LIFE SCIENCES CONFERENCE
04/04/2019
Nes-Ziona, Israel, April 04, 2019 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq:ENLV), a clinical-stage immunotherapy company, today announced that company management will make a corporate presentation at the H. [...]
Pluristem Therapeutics Inc. Announces Pricing of Its Public Offering and Registered Direct Offering for Aggregate Proceeds of Approximately $20 Million
04/04/2019
HAIFA, Isreal, April 04, 2019 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq: PSTI, TASE: PLTR) (“Pluristem” or “Company”), a leading regenerative medicine company developing novel placenta-based cell therapy [...]
ATW Tech Announces Revenue Growth of 13% for 2018 to Reach $12.0m
04/04/2019
MONTREAL, April 04, 2019 (GLOBE NEWSWIRE) -- ATW Tech Inc. (the “Company”) (TSX-V: ATW) announces its annual financial results for the year ended December 31, 2018. The Company generated year-over-year revenue growth of [...]
ATW Tech annonce des revenus en croissance de 13% en 2018 pour atteindre 12m$
04/04/2019
MONTRÉAL, 04 avr. 2019 (GLOBE NEWSWIRE) -- ATW Tech Inc. (la « Société ») (TSX-V : ATW) annonce aujourd'hui ses résultats pour son exercice terminé le 31 décembre 2018. Pour 2018, la Société a généré une croissance des [...]
Teligent, Inc. Announces FDA Approval of Fluocinonide Cream USP, 0.1%
04/04/2019
BUENA, N.J., April 04, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]
CB2 Insights Acquires Multi-Location Medical Cannabis Clinic Group, Relaxed Clarity
04/04/2019
Accretive acquisition of Colorado-based clinic group bolsters Company’s US medical cannabis clinical roll-up strategy; adds 15,000 new patients TORONTO, April 04, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or the “ [...]
Paratek Pharmaceuticals Presenting New Data from NUZYRA™ (Omadacycline) Development Program at ECCMID 2019
04/04/2019
Data Highlight Paratek’s Commitment to Further Understanding Omadacycline’s Utility in Life-Threatening Infections such as CABP and ABSSSI BOSTON, April 04, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq [...]
SELLAS Life Sciences Group and World-Renowned Cancer Center to Study Galinpepimut-S (GPS) in Combination with Nivolumab in Patients with Malignant Pleural Mesothelioma (MPM)
04/04/2019
Initiation of Phase 1 Clinical Trial in Relapsed or Refractory MPM Expected in the Second Quarter of 2019 Previous Combination Study of GPS and Nivolumab Given After Salvage Chemotherapy in Ovarian Cancer Patients [...]
PSIQ Reports Record Breaking Annual Revenues of $ 876,448 for 2018 as Compared to $ 208,236 for 2017, an Increase of Over 400% and Poised for Rapid Expansion in 2019
04/04/2019
SUNRISE, Fla., April 04, 2019 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) announced today that its wholly owned subsidiary, Elite Products International, Inc. (“Elite”), reported Revenues for the year [...]
Abeona Therapeutics Receives FDA Fast Track Designation for ABO-101 for Treatment of Sanfilippo Syndrome Type B (MPS IIIB)
04/04/2019
Ongoing Phase 1/2 study of ABO-101 enrolling eligible patients with MPS IIIB NEW YORK and CLEVELAND, April 04, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in cell and gene [...]
Gritstone Oncology Announces the Addition of Eugene Zhukovsky, Expert in Bispecific Biotherapeutics Development, to its Scientific Advisory Board
04/04/2019
EMERYVILLE, Calif., April 04, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer [...]
Aptinyx to Present at 18th Annual Needham Healthcare Conference
04/04/2019
EVANSTON, Ill., April 04, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, [...]
Entasis Therapeutics Initiates Global Phase 3 Pivotal Trial of ETX2514SUL for Patients with Carbapenem-Resistant Acinetobacter Infections
04/04/2019
WALTHAM, Mass., April 04, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company developing novel antibacterials to treat serious drug-resistant infections [...]
Final Results from The Heart EXPAND Pivotal Trial Using the Organ Care System (OCS) Heart Technology Presented at the 2019 Annual Meeting of The International Society for Heart and Lung Transplantation in Orlando
04/04/2019
ANDOVER, Mass., April 04, 2019 (GLOBE NEWSWIRE) -- TransMedics, Inc., a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, announced the [...]
Alpha Pro Tech, Ltd. Announces the Launch of Three New Products Expanding Building Supply Market Opportunity
04/04/2019
TECHNO SB® 25 & TECHNO SB® ULTRA Synthetic Roof Underlayment REXTREME Premium Window and Door Flashing Nogales, Ariz., April 04, 2019 (GLOBE NEWSWIRE) -- Alpha Pro Tech, Ltd. (NYSE American: APT) , a leading [...]
Samumed Doses First Subject in Phase 1 Trial of SM07883, a Potential Treatment for Alzheimer’s Disease
04/04/2019
DYRK1A Inhibition as a Potential Treatment for Alzheimer’s Disease Supported by Data Presented at International Conference on Alzheimer's and Parkinson's Diseases (AD/PD™ 2019) SAN DIEGO, April 04, 2019 (GLOBE NEWSWIRE [...]
Allan Oberman Appointed Chairman of Jay Pharma’s Board of Directors
04/04/2019
TORONTO, April 04, 2019 (GLOBE NEWSWIRE) -- Jay Pharma Inc., a company dedicated to developing innovative, evidence-based cannabinoid medicines to address unmet patient needs in cancer care, today announced the [...]

Pages